GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lyra Therapeutics LYRA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.19

—

Close of 5 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Lyra Therapeutics

Our reporting

We have not reported on Lyra Therapeutics yet.

Next results

17 Nov 2026

Due on 17 Nov 2026. Analysts expect earnings of -1.63 a share on revenue of $99,500.

Past results

Reported against what analysts expected

12 Mar 202612 Nov 202512 Aug 20256 May 202513 Mar 202512 Nov 2024
Earnings per share-7.14-3.38-5.51-6.00-8.00-9.00
Forecast-2.59-5.98-5.79-7.50-6.00-10.75
Revenue$200,000$25,000$191,500$183,000$209,000$195,000
Forecast$440,000$205,667$292,500$240,000$206,000$315,600

Key events

  1. 28 May 202550-to-1 reverse split
  2. 1 May 2020Listed

Lyra Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.